SEC Info  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Qorvo, Inc. – ‘8-K’ for 5/11/21

On:  Monday, 5/17/21, at 4:07pm ET   ·   For:  5/11/21   ·   Accession #:  1604778-21-22   ·   File #:  1-36801

Previous ‘8-K’:  ‘8-K’ on / for 5/12/21   ·   Next:  ‘8-K’ on / for 6/8/21   ·   Latest:  ‘8-K’ on / for 1/31/24

Find Words in Filings emoji
 
  in    Show  and   Hints

  As Of               Filer                 Filing    For·On·As Docs:Size

 5/17/21  Qorvo, Inc.                       8-K:5       5/11/21   11:252K

Current Report   —   Form 8-K

Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 8-K         Current Report                                      HTML     31K 
 7: R1          Document and Entity Information Document            HTML     46K 
 9: XML         IDEA XML File -- Filing Summary                      XML     12K 
 6: XML         XBRL Instance -- rfmd-20210511_htm                   XML     21K 
 8: EXCEL       IDEA Workbook of Financial Reports                  XLSX      6K 
 3: EX-101.DEF  XBRL Definitions -- rfmd-20210511_def                XML     38K 
 4: EX-101.LAB  XBRL Labels -- rfmd-20210511_lab                     XML     77K 
 5: EX-101.PRE  XBRL Presentations -- rfmd-20210511_pre              XML     38K 
 2: EX-101.SCH  XBRL Schema -- rfmd-20210511                         XSD     10K 
10: JSON        XBRL Instance as JSON Data -- MetaLinks               13±    19K 
11: ZIP         XBRL Zipped Folder -- 0001604778-21-000022-xbrl      Zip     34K 


‘8-K’   —   Current Report


This is an HTML Document rendered as filed.  [ Alternative Formats ]



 iX:   C:  C: 
  rfmd-20210511  
 i 0001604778 i false00016047782021-05-112021-05-11

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM  i 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

 i May 11, 2021
(Date of earliest event reported)
rfmd-20210511_g1.jpg
 i Qorvo, Inc.
(Exact name of registrant as specified in its charter)
 i Delaware
 i 001-36801 i 46-5288992
(State or Other Jurisdiction of Incorporation)
(Commission File Number)
(I.R.S. Employer Identification No.)
 i 7628 Thorndike Road,  i Greensboro,  i North Carolina  i 27409-9421
(Address of principal executive offices)
(Zip Code)

( i 336)  i 664-1233
Registrant's telephone number, including area code

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 i  Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
 i  Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
 i  Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
 i  Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:
Title of each classTrading Symbol(s)Name of each exchange on which registered
 i Common Stock, $0.0001 par value i QRVO i The Nasdaq Stock Market LLC

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company  i 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. o





Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

Fiscal Year 2022 Performance-Based Restricted Stock Award Targets and Performance Criteria
On May 11, 2021, the Compensation Committee (the “Committee”) of the Board of Directors (the “Board”) of Qorvo, Inc. (the “Company”) approved awards of performance-based restricted stock units (“Awards”) in accordance with the Qorvo, Inc. 2012 Stock Incentive Plan, as amended (the “2012 Plan”), to each of the Company’s named executive officers. The purpose of these Awards is to link a portion of each named executive officer’s equity compensation to achievement of key Company initiatives that the Committee believes have a strong potential to impact longer-term stockholder value creation. The fair market value for each share of restricted stock underlying each Award was established by the Committee in accordance with the 2012 Plan at $172.01 per share, which was the closing price of the Company’s common stock as reported on the Nasdaq Global Select Market on May 11, 2021. Each Award, in addition to being subject to customary terms and conditions as set forth in the 2012 Plan and respective Award agreement, is subject to specified performance and service conditions and represents a contingent right to receive an amount of the Company’s common stock at a future date.

Each Award will be earned by each named executive officer to the extent the Company achieves at least one, and up to ten, performance objectives (the “Performance Objectives”) established by the Committee. Seven of the Performance Objectives have between two and seven sub-objectives that can be separately met. Seven Performance Objectives must be satisfied during the Company’s current fiscal year ending April 2, 2022, one Performance Objective must be completed by June 30, 2022, one Performance Objective must be completed by July 2, 2022, and one Performance Objective must be completed no later than September 30, 2022 (each a “Measurement Date”). Each Performance Objective and sub-objective is separately weighted and expressed as a percentage of a target number of common shares. If a Performance Objective or sub-objective is met, the named executive officer will be granted an Award for a number of shares equal to the target multiplied by the applicable percentage earned and assigned to such Performance Objective or sub-objective. The named executive officer may earn up to 150% of the target number of Awards if all ten Performance Objectives are met in full. The Performance Objectives relate to securing specific design wins; making specific R&D-related improvements; implementing operational improvements; developing, expanding or qualifying specific product and process technologies; implementing specific manufacturing-related improvements; updating the Company’s governance framework and related monitoring and disclosure to support the Company’s environmental, social and governance (ESG) program; and developing and expanding the business application of advanced analytics. The shares of restricted stock earned by the named executive officer with respect to a Performance Objective, if any, will vest over a three-year period, with 50% vesting upon certification of the level of achievement by the Committee after the applicable Measurement Date for the applicable Performance Objective and the remaining 50% vesting in equal annual installments over each of the following two years. No shares are issued unless, and then only to the extent that, an Award is both earned and vested.

Subject to satisfaction of the Performance Objectives, each named executive officer will be eligible to receive shares of restricted common stock of the Company up to the maximum number of shares set forth below:





Name
Maximum Award
(if all ten Performance Objectives are fully achieved)

Robert A. Bruggeworth
40,026
President and Chief Executive Officer
15,698
Chief Financial Officer
Steven E. Creviston
12,035
Corporate Vice President and
President of Mobile Products
James L. Klein
8,372
Corporate Vice President and
President of Infrastructure and Defense Products
Paul J. Fego
12,035
Corporate Vice President of Global Operations





SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

Qorvo, Inc.
By:
Chief Financial Officer

Date:    May 17, 2021



Dates Referenced Herein   and   Documents Incorporated by Reference

This ‘8-K’ Filing    Date    Other Filings
9/30/22
7/2/22
6/30/22
4/2/2210-K,  5
Filed on:5/17/214
For Period end:5/11/214
 List all Filings 
Top
Filing Submission 0001604778-21-000022   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
AboutPrivacyRedactionsHelp — Wed., Apr. 24, 11:09:47.2am ET